Company Filing History:
Years Active: 2009-2011
Title: The Innovations of Loren C. Denlinger
Introduction
Loren C. Denlinger is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of functional genomics, particularly in the area of white blood cell assays. With a total of two patents to his name, Denlinger has developed innovative methods that enhance the understanding of nucleotide receptor activity in mixed cell populations.
Latest Patents
Denlinger's latest patents include a "Functional genomic pore assay for mixed cell populations" and a "White blood cell functional assay." The first patent provides a method for assaying nucleotide receptor P2X pore activity in white blood cells within a mixed cell sample. This method involves labeling white blood cells, depolarizing them, and analyzing dye uptake to quantify P2X pore activity. The second patent outlines a rapid method for assaying nucleotide receptor P2X pore activity in white blood cells contained within a blood sample, utilizing similar steps to achieve accurate quantification.
Career Highlights
Loren C. Denlinger is associated with the Wisconsin Alumni Research Foundation, where he continues to advance research in his field. His work has implications for understanding immune responses and developing therapeutic strategies.
Collaborations
Denlinger has collaborated with notable colleagues such as Kirk Jeffrey Hogan and Paul J. Bertics, contributing to a dynamic research environment that fosters innovation.
Conclusion
Loren C. Denlinger exemplifies the spirit of innovation in the field of functional genomics. His patents reflect a commitment to advancing scientific knowledge and improving methodologies in medical research.